Battling Malaria with Chloroquine in India
Author Information
Author(s): Vinod P Sharma
Primary Institution: Centre for Rural Development and Technology, Indian Institute of Technology, Hauz Khas, New Delhi, India
Hypothesis
The continuation of chloroquine as a first-line treatment for malaria in India is ineffective against drug-resistant Plasmodium falciparum.
Conclusion
The current reliance on chloroquine is counterproductive, and a switch to artemisinin-based combination therapy is necessary for effective malaria control in India.
Supporting Evidence
- Chloroquine is still used as the first-line treatment despite high levels of resistance.
- Switching to artemisinin-based combination therapy is recommended for better efficacy.
- Malaria incidence is significantly under-reported in India.
Takeaway
Malaria is a big problem in India, and using an old medicine called chloroquine isn't working anymore. We need to use a new medicine to help people get better.
Methodology
The commentary discusses the current malaria treatment policies and the effectiveness of chloroquine versus artemisinin-based combination therapy.
Potential Biases
Potential bias in the reliance on outdated treatment protocols and the influence of funding sources on drug policy.
Limitations
The commentary does not provide original research data but critiques existing policies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website